TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-19

Archived explainer. For the current picture see today's SLS page.

Why Is SELLAS LIFE SCIENCES (SLS) Stock Down Today?

By the Top Tier Newswire AI Desk · November 19, 2026 at 10:20 AM ET · reviewed against 11 wire stories

SELLAS LIFE SCIENCES (SLS) is down -15.99% in the latest session. Our newswire has captured 11 stories on SLS across 8 sources in the last 36 hours, with AI sentiment reading bearish (avg 35/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

SELLAS Life Sciences (SLS) shares fell 15.99% to $15.08 following the pricing of a $150 million underwritten public offering. The company sold 11.54 million shares of common stock at $13 per share, a price that triggered significant selling pressure despite recent positive clinical trial results.

What Happened

The company announced the pricing of its offering on November 18, 2026. The transaction generated expected gross proceeds of $150 million. This move followed positive topline results from the pivotal Phase 3 REGAL trial, which had previously sent shares up 156% in a single session. The offering price represented a discount to the prior close of $17.95, leading to a steep decline in the stock. Retail traders expressed frustration with the pricing, describing it as a "crazy low price" given the recent momentum. The offering was structured as an underwritten public offering of common stock.

What The Data Shows

The stock opened at $13.97, marking a 22.2% gap down from the previous close of $17.95. Trading volume reached 14.2 million shares, which is 1.8 times the three-month daily average. The session high was $16.54, while the low was $13.88. The company has a market capitalization of $3.9 billion and remains unprofitable with a trailing twelve-month earnings per share of -0.20. The stock has a beta of 2.70 and a 52-week range of $1.39 to $24.89. Over the last eight sessions, the stock had moved up 109.2%. Unusual options activity included eight notable prints with a call premium of $11.1 million and no put premium. The largest single print was $4.2 million. The stock printed six fresh 52-week highs and one fresh 52-week low on November 19, 2026.

What To Watch

Investors will monitor the closing of the offering on November 20. Attention will also focus on any further updates regarding the REGAL trial and the company's broader pipeline developments.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

SLS by the numbers

Last: $15.08Session: -15.99%7 sessions: +77.54%Coverage: 11 stories / 8 sourcesAI sentiment: 35/100 (bearish)Mkt cap: $3.9B52w: $1.39 to $24.89
SLS · Nov 19 session (5-min) · -17.02% vs prior close · updated 6:57 PM ET
$13.82$16.00$18.18prev close $17.95$14.897:00 AM9:58 AM12:57 PM3:56 PM6:55 PM7:00 AM · $14.457:05 AM · $14.507:10 AM · $14.137:15 AM · $14.067:20 AM · $14.377:25 AM · $14.307:30 AM · $14.467:35 AM · $14.407:40 AM · $14.487:45 AM · $14.217:50 AM · $14.197:55 AM · $14.208:00 AM · $14.058:05 AM · $14.058:10 AM · $14.058:15 AM · $14.258:20 AM · $14.098:25 AM · $14.178:30 AM · $14.568:35 AM · $14.498:40 AM · $14.568:45 AM · $14.608:50 AM · $14.818:55 AM · $14.999:00 AM · $15.359:05 AM · $15.259:10 AM · $15.479:15 AM · $15.409:20 AM · $15.709:25 AM · $15.419:30 AM · $16.109:35 AM · $15.639:40 AM · $15.829:45 AM · $15.289:50 AM · $15.659:55 AM · $15.6110:00 AM · $15.6110:05 AM · $15.7910:10 AM · $15.7610:15 AM · $15.0810:20 AM · $15.2910:25 AM · $14.7910:30 AM · $14.5610:35 AM · $14.9410:40 AM · $14.8910:45 AM · $14.7110:50 AM · $14.9110:55 AM · $14.9211:00 AM · $14.9511:05 AM · $14.9611:10 AM · $14.7111:15 AM · $14.6811:20 AM · $14.6811:25 AM · $14.6311:30 AM · $14.6911:35 AM · $14.6911:40 AM · $14.8811:45 AM · $14.7511:50 AM · $14.6011:55 AM · $14.6812:00 PM · $14.5512:05 PM · $14.5612:10 PM · $14.5812:15 PM · $14.7112:20 PM · $14.8112:25 PM · $14.8512:30 PM · $14.6912:35 PM · $14.7012:40 PM · $14.6612:45 PM · $14.6412:50 PM · $14.6812:55 PM · $14.781:00 PM · $14.701:05 PM · $14.771:10 PM · $14.771:15 PM · $14.831:20 PM · $14.801:25 PM · $14.841:30 PM · $14.841:35 PM · $14.821:40 PM · $14.711:45 PM · $14.631:50 PM · $14.591:55 PM · $14.552:00 PM · $14.632:05 PM · $14.622:10 PM · $14.592:15 PM · $14.492:20 PM · $14.402:25 PM · $14.512:30 PM · $14.482:35 PM · $14.392:40 PM · $14.402:45 PM · $14.282:50 PM · $14.282:55 PM · $14.283:00 PM · $14.353:05 PM · $14.473:10 PM · $14.493:15 PM · $14.543:20 PM · $14.563:25 PM · $14.553:30 PM · $14.623:35 PM · $14.863:40 PM · $15.033:45 PM · $14.903:50 PM · $14.673:55 PM · $14.864:00 PM · $14.784:05 PM · $14.764:10 PM · $14.744:15 PM · $14.804:20 PM · $14.874:25 PM · $14.974:30 PM · $14.884:35 PM · $14.864:40 PM · $14.764:45 PM · $14.754:50 PM · $14.834:55 PM · $14.735:00 PM · $14.755:10 PM · $14.865:20 PM · $14.835:25 PM · $14.925:30 PM · $14.925:35 PM · $14.925:45 PM · $14.835:55 PM · $14.846:00 PM · $14.886:05 PM · $14.886:10 PM · $14.866:15 PM · $14.906:20 PM · $14.876:25 PM · $14.896:30 PM · $14.906:35 PM · $14.856:40 PM · $14.866:45 PM · $14.916:50 PM · $14.916:55 PM · $14.89
AI sentiment, last 36h · averaged over 11 stories · 35/100 bearish
AI sentiment 35/100 (bearish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishStockTitan · sentiment 24 · SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public OfferingStockTitan · 24SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public OfferingStocktwits News · sentiment 28 · SLS Stock Plunges Overnight As Sellas’ Discounted Share Offering Has Retail Bulls Crying Foul: ‘Crazy Low Price’Stocktwits News · 28SLS Stock Plunges Overnight As Sellas’ Discounted Share Offering Has Retail Bulls Crying …The Fly · sentiment 28 · Sellas Life Sciences 11.5M share Secondary priced at $13.00The Fly · 28Sellas Life Sciences 11.5M share Secondary priced at $13.00Seeking Alpha · sentiment 22 · SELLAS Life Sciences prices $150M public offering of common stockSeeking Alpha · 22SELLAS Life Sciences prices $150M public offering of common stockGuruFocus · sentiment 24 · SELLAS Life Sciences Group (SLS) Prices $150M Public Offering Ahead of November 20 ClosingGuruFocus · 24SELLAS Life Sciences Group (SLS) Prices $150M Public Offering Ahead of November 20 ClosingStocktwits News · sentiment 62 · Stock Futures Climb Ahead Of Anthropic's Nasdaq Debut — NVDA, BABA, TTWO, SLS Stocks In FocusStocktwits News · 62Stock Futures Climb Ahead Of Anthropic's Nasdaq Debut — NVDA, BABA, TTWO, SLS Stocks In F…MarketWatch · sentiment 22 · Sellas Life Sciences Shares Sink After Pricing Public OfferingMarketWatch · 22Sellas Life Sciences Shares Sink After Pricing Public OfferingThe Fly · sentiment 31 · Sellas Life Sciences falls -13.8%The Fly · 31Sellas Life Sciences falls -13.8%
1d agoThe FlyBEARISH 31General

Sellas Life Sciences falls -13.8%

1d agoMarketWatchBEARISH 22General

Sellas Life Sciences Shares Sink After Pricing Public Offering

1d agoStocktwits NewsBULLISH 62General

Stock Futures Climb Ahead Of Anthropic's Nasdaq Debut — NVDA, BABA, TTWO, SLS Stocks In Focus

Oil futures edged higher as traders weighed supply glut concerns against rising tensions in the Strait of Hormuz.

1d agoGuruFocusBEARISH 24General

SELLAS Life Sciences Group (SLS) Prices $150M Public Offering Ahead of November 20 Closing

1d agoSeeking AlphaBEARISH 22General

SELLAS Life Sciences prices $150M public offering of common stock

SELLAS Life Sciences Group (SLS) priced an underwritten public offering of 11.54M shares of common stock at $13 per share, generating expected gross proceeds of $150M

1d agoThe FlyBEARISH 28General

Sellas Life Sciences 11.5M share Secondary priced at $13.00

1d agoStocktwits NewsBEARISH 28General

SLS Stock Plunges Overnight As Sellas’ Discounted Share Offering Has Retail Bulls Crying Foul: ‘Crazy Low Price’

The offering price was still 74% above Monday’s close after positive leukemia trial results sent shares up 156% on Tuesday.

1d agoStockTitanBEARISH 24General

SELLAS Life Sciences Announces Pricing of $150.0 Million Underwritten Public Offering

NEW YORK, Nov. 18, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of...

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on SLS: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier SLS move explainers: 2026-11-20 · 2026-11-19 · 2026-11-18 · 2026-11-17 · 2026-11-13 · 2026-10-28 · 2026-10-20 · 2026-10-19 · 2026-08-31 · 2026-08-28 · 2026-08-27 · 2026-08-25 · 2026-08-24 · 2026-08-21 · 2026-08-17